Statistics for Faron Pharmaceuticals Oy (id:3716 FARN)
Valuation metrics
Market cap
159.55M
Enterprise value
116.74M
Trailing P/E (ttm)
-296.88
Forward P/E
-5.77
PEG ratio
-5.77
Price/Sales (ttm)
Price/Book (mrq)
11.54K
Enterprise Value/Revenue
Enterprise Value/EBITDA
-5.20
Overview
Shares outstanding
104.62M
Float
73.58M
Shares short
% Held by insiders
0.32%
% Held by institutions
0.11%
Average volume (10 days)
13.55K
Average volume (90 days)
Price summary
52-Week low
85.00
52-Week high
370.00
52-Week change
-85.96%
Beta
0.33
50-Day moving average
197.70
200-Day moving average
165.24
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
December 31th, 2023
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-70.00%
Return on equity
204.10%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-22,453,767.00
Net income to common (ttm)
-26,418,802.00
Diluted EPS (ttm)
-0.31
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
25.06M
Total cash per share (mrq)
0.29
Total debt (mrq)
10.63M
Total Debt/Equity (mrq)
922.55
Current ratio (mrq)
144.60%
Book value per share (mrq)
0.01
Cash flow
Cash flow statement
-16,846,384.00
Levered free cash flow (LFCF)
-4,412,292.00